10Matsuda I,Nagata N,Matsuura T,et al.Retrospective survey of urea cycle disorders:Part 1.Clinical and laboratory observations of thirty-two Japanese male patients with ornithine transcarbamylase deficiency[J].Am J Med Genet,1991,38:85-89.
1Beigel R, Beigel Y. Homozygous familial hypereholesterolemia : Long term clinical course and plasma exchange therapy for two individual patients and review of the literature. J Clin Apher, 2009, 24:219-224.
2Rees A. Familial hypereholesterolaemia: underdiagnosed and undertreated. Eur heart J, 2008, 29:2583-2584.
3Piran S, Amato D. Gaucher disease: a systematic review and meta-analysis of bone complications and their response to treat- ment. J Inherit Metab Dis, 2010, 33:271-279.
4Li H, Haurigot V, Doyon Y, et al. In vivo genome editing re- stores haemostasis in a mouse model of haemophilia. Nature, 2011, 475:217-221.
5Yan JB, Xu HP, Xiong C, et al. Rapid and reliable detection of glucose-6-phosphate dehydrogenase ( G6PD ) gene mutations in han chinese using high-resolution melting analysis. J Mol Diagn, 2010, 12:305-311.
6Clarke JTR. Aelinieal guide to inherited metabolic diseases. 2nd ed. Carfibridge : Cambridge University Press, 2002, 255-273.
7Meli C, Bianca S. Dietary control of phenylketonuria. Lancet, 2002, 360: 2075-2076.
8Sire KG, Hammond J, Wileken B. Strategies for the diagnosis of mitochondrial fatty acid beta-oxidation disorders. Clin Chim Acta, 2002, 323:37-58.
9E1-Karaksy H, Rashed M, E1-Sayed R, et al. Clinical prac- tice: NTBC therapy for tyrosinemia type 1: how much is enough? Eur J Pediatr, 2010, 169:689-693.
10Gillis L, Kaye E. Diagnosis and management of mitochondrial diseases. Pediatr Clin North Am, 2002, 49:203-219.
